BMRN EPS Estimates
BioMarin Pharmaceutical Inc.
$56.03
-$0.09(-0.16%)
47
Overall
70
Value
20
Tech
52
Quality
Market Cap
$10.85B
Volume
2.73M
52W Range
$49.26 - $70.98
Target Price
$89.23
BMRN EPS estimates: the consensus estimate for BioMarin Pharmaceutical Inc.'s current fiscal year is $2.59 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
BMRN EPS Estimates
- EPS estimate, current quarter
- $-0.30
- EPS estimate, next quarter
- $1.40
- EPS estimate, current year
- $2.59
- EPS estimate, next year
- $5.31
- EPS growth, 3-year
- -24.22%
| Fiscal year | EPS |
|---|---|
| 2015 | $-1.07 |
| 2014 | $-0.92 |
| 2013 | $-1.28 |
| 2012 | $-0.95 |
| 2011 | $-0.48 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BMRN | $56.03 | -0.2% | 2.73M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get BioMarin Pharmaceutical Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW